YASMIN 28 TABLET

البلد: كندا

اللغة: الإنجليزية

المصدر: Health Canada

العنصر النشط:

DROSPIRENONE; ETHINYL ESTRADIOL

متاح من:

BAYER INC

ATC رمز:

G03AA12

INN (الاسم الدولي):

DROSPIRENONE AND ESTROGEN

جرعة:

3MG; 0.03MG

الشكل الصيدلاني:

TABLET

تركيب:

DROSPIRENONE 3MG; ETHINYL ESTRADIOL 0.03MG

طريقة التعاطي:

ORAL

الوحدات في الحزمة:

28

نوع الوصفة الطبية :

Prescription

المجال العلاجي:

CONTRACEPTIVES

ملخص المنتج:

Active ingredient group (AIG) number: 0250430001; AHFS:

الوضع إذن:

APPROVED

تاريخ الترخيص:

2004-12-10

خصائص المنتج

_ _
_YASMIN Product Monograph _
_ _
_Page 1 of 58 _
_ _
PRODUCT MONOGRAPH
PR
YASMIN
® 21
PR
YASMIN
® 28
Drospirenone and Ethinyl Estradiol Tablets, Bayer Standard
3.0 mg drospirenone and 0.030 mg ethinyl estradiol
Oral Contraceptive
Acne Therapy
Bayer Inc.
2920 Matheson Boulevard East
Mississauga, Ontario
L4W 5R6
Canada
http://www.bayer.ca
Date of Revision:
April 8, 2021
Submission Control No: 196901
©2017, Bayer Inc.
® TM see www.bayer.ca/tm-mc
_ _
_YASMIN Product Monograph _
_ _
_Page 2 of 58 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
..................................................................................................14
DRUG INTERACTIONS
..................................................................................................18
DOSAGE AND ADMINISTRATION
..............................................................................25
OVERDOSAGE
................................................................................................................27
ACTION AND CLINICAL PHARMACOLOGY
............................................................28
STORAGE AND STABILITY
..........................................................................................32
SPECIAL HANDLING INSTRUCTIONS
.......................................................................32
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................32
PART II: SCIENTIFIC INFORMATION
...........................................................................